阿仑单抗诱发的复发缓解型多发性硬化症患者瘀点和鼻出血：一例报告
Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis: A case report.
作者信息
Mahmoudi Farhad, Emami Sayed Ali, Masaeli Farid, Rayatpisheh Najmeh
机构信息
School of Medicine Isfahan University of Medical Sciences Isfahan Iran.
School of Medicine Shahrekord University of Medical Sciences Shahrekord Iran.
出版信息
Clin Case Rep. 2023 Nov 25;11(11):e8143. doi: 10.1002/ccr3.8143. eCollection 2023 Nov.
Abstract
Here, we present a case of relapsing-remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care.
摘要
在此，我们报告一例复发缓解型多发性硬化症患者，在接受第二剂阿仑单抗治疗后出现瘀点和鼻出血。本研究突出了此类效应，强调随着阿仑单抗使用量的增加需保持警惕。及时识别和处理对患者护理至关重要。
Zotero 插件